CHOLAFIN - IntraDay Trade Analysis with Live Signals
← Back to ListKey Parameters
⭐ IntraDay Trade Rating: 2.3
Show all parameters (20 more)
🧾 Trade Setup
Buy Price: 1,770 ₹ (slightly below current level). Stop Loss Level 1: 1,750 ₹ (protect against immediate downside if analyst concerns materialize). Exit Level 1: 1,800 ₹ (target profit based on momentum – volume confirms buying interest) Exit Level 2: 1,735 ₹ (if the stock stalls or shows signs of weakness after reaching 1,800). Overall verdict: Trading is cautiously optimistic given strong volume and earnings growth, but risk management is paramount due to elevated valuation and negative analyst signals.
✅ Positive
Strong PAT growth this quarter, up 45.6% year-on-year, suggests continued operational strength. The DII holding has increased significantly (0.71%), indicating growing institutional interest which could fuel further momentum today. Volume is very high – nearly double the average weekly volume – suggesting substantial buying pressure.
⚠️ Limitation
The Stock P/E of 26.5 is elevated relative to the industry PE of 19.9, reflecting investor enthusiasm but also potential overvaluation. The Debt-to-Equity ratio of 6.94 indicates a high level of leverage which increases financial risk; this could trigger a profit-taking reaction if earnings expectations aren't met.
📉 Company Negative News
“Cholamandalam Investment and Finance Company Stock Signals to Wat - Univest” suggests potential negative analyst coverage, creating immediate selling pressure. "Top stocks to buy: Stock recommendations for September 15, 2026 week - check list - The Times of India" indicates the stock is flagged by analysts as being on a watch list, which could signal concerns about its prospects.
🏭 Industry
The financial sector is currently facing headwinds due to rising interest rates and tighter credit conditions, however, Cholamandalam’s focused lending portfolio in vehicle and equipment finance appears relatively resilient compared to broader banking exposure. The industry PE of 19.9 suggests a generally positive outlook, but the stock's premium valuation warrants careful consideration.